Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population
CONCLUSION: Among the sparse studies available, the present one demonstrates all SLCO1B1 and CYP2C9 function-impairing alleles among Emiratis. We highlighted how population-specific pharmacogenomic data can predict safer choices of statins, especially in understudied populations.PMID:38284696 | DOI:10.2174/0115701611283841231227064343
Source: Current Vascular Pharmacology - Category: Drugs & Pharmacology Authors: Mais N Alqasrawi Zeina N Al-Mahayri Hiba Alblooshi Habiba Alsafar Bassam R Ali Source Type: research
More News: Cholesterol | Crestor | Drugs & Pharmacology | Fluvastatin | Genetics | Organic | Rosuvastatin | Statin Therapy | Study | UAE Health